The current study was a meta-analysis of 18 large, prospective, randomized, controlled studies with a total of 4146 patients. The included studies had "cardiovascular," "mortality," or "blood pressure ...

The obesity and diabetes medication tirzepatide (Mounjaro, Zepbound) reduced obstructive sleep apnea events by as much as two-thirds in new clinical trials. The abstract (but not the complete study) ...

A repurposed epilepsy drug called sultiame cut breathing interruptions during sleep by up to 50% in adults with ...

The weight-loss drug Zepbound was linked to a reduction in obstructive sleep apnea (OSA), according to new research. Pharmaceutical manufacturer Eli Lilly on Wednesday said injections of its obesity ...

Add Yahoo as a preferred source to see more of our stories on Google. Inspire Sleep Apnea Innovation Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or ...

Eli Lilly’s weight loss drug Zepbound was found to reduce obstructive sleep apnea in adults with obesity, the drugmaker said in a release Wednesday. Obstructive sleep apnea affects about 39 million ...

A CPAP machine is a medical device often recommended to folks who have sleep apnea or other disruptive sleep conditions. Wearers place a mask over their nose and mouth to deliver a continuous stream ...

A late-stage trial of Eli Lilly’s weight loss drug Zepbound showed promising results in treating sleep apnea symptoms in obese adults, the company announced Wednesday, the latest findings suggesting ...